Skip to content
MedCompare

Crizotinib

Also known as Xalkori (us), Crizonix (india)

Cancer & Oncology
Save $10,401/mo
20× cheaper

Crizotinib is used to treat certain types of non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body.

United States
$10,958
per month
India
$557
per month
You save
$10,401
95% cheaper in India
3K US scripts/yr$30.7M potential annual savings$32.3M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC21H22Cl2FN5O

SMILES: C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N

Compare the price
US price$10,958per month
India price$557per month
You save$10,40195% less

Based on 30 units per month. US $365.28 vs India $18.58 per unit.

Total over 1 periodSave $10,401$10,958 → $557
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$62,407
Estimated travel cost
− $2,300
Net savings after travel
$60,107

Even after travel, you could come out ahead by about $60,107.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Crizotinib is filled about 3K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$32.3M
If sourced from India
$1.6M
Potential annual savings
$30.7M
−95%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.